Can Bioxin (cefexime) be combined with Augmentin (amoxicillin‑clavulanate) and a proton‑pump inhibitor for peptic ulcer disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Bioxin (Clarithromycin) Be Combined with Augmentin and a PPI for Peptic Ulcer Disease?

No, you should not use Bioxin (clarithromycin) with Augmentin (amoxicillin-clavulanate) and a PPI for peptic ulcer disease—this combination is not evidence-based and the clavulanate component of Augmentin serves no purpose in H. pylori eradication.

The Correct Approach to PUD Treatment

If H. pylori is Present (Most Common Scenario)

The standard first-line regimen for H. pylori eradication in peptic ulcer disease consists of a high-dose PPI twice daily, amoxicillin (not Augmentin), clarithromycin, and ideally metronidazole for 14 days. 1, 2

  • Bismuth quadruple therapy is the preferred first-line treatment in most regions: high-dose PPI twice daily + bismuth subsalicylate 262 mg four times daily + metronidazole 500 mg three to four times daily + tetracycline 500 mg four times daily for 14 days, achieving 80-90% eradication rates even in areas with high clarithromycin resistance. 1

  • If using a clarithromycin-based regimen (only in areas with documented clarithromycin resistance <15%): Use esomeprazole or rabeprazole 40 mg twice daily + clarithromycin 500 mg twice daily + amoxicillin 1000 mg twice daily + metronidazole 500 mg twice daily for 14 days (concomitant non-bismuth quadruple therapy). 1, 2

Why Augmentin Is Wrong

  • Amoxicillin alone (without clavulanate) is the beta-lactam of choice for H. pylori eradication. The clavulanate component in Augmentin provides no additional benefit against H. pylori and only increases the risk of adverse effects, particularly diarrhea. 1, 3

  • All major guidelines specify plain amoxicillin 1000 mg twice daily, not amoxicillin-clavulanate combinations. 4, 1

If H. pylori is Absent (Less Common)

  • For non-H. pylori peptic ulcers (often NSAID-related), treatment consists of a PPI alone for 4-8 weeks to allow mucosal healing. 4, 5 Antibiotics including clarithromycin and amoxicillin are not indicated.

  • PPIs should be continued for 6-8 weeks following endoscopic treatment of peptic ulcer bleeding to allow mucosal healing. 4

Critical Optimization Factors

  • High-dose PPI twice daily is mandatory: Esomeprazole or rabeprazole 40 mg twice daily increases cure rates by 8-12% compared to standard-dose PPIs. 1

  • 14-day duration is required: Extending treatment from 7 to 14 days improves eradication success by approximately 5%. 4, 1, 2

  • Test for H. pylori in all PUD patients: All patients with peptic ulcers should be tested for H. pylori and receive eradication therapy if positive, with subsequent confirmation of eradication. 4, 5, 1

Common Pitfalls to Avoid

  • Never use Augmentin instead of plain amoxicillin for H. pylori eradication—the clavulanate adds no benefit and increases side effects. 1

  • Do not use clarithromycin-based triple therapy empirically in most regions—clarithromycin resistance now exceeds 15-20% in most of North America and Europe, making bismuth quadruple therapy the preferred first-line option. 1

  • Never use once-daily PPI dosing for eradication therapy—twice-daily high-dose PPI is essential for optimal outcomes. 1

  • Do not shorten therapy below 14 days—this significantly reduces eradication success. 4, 1

References

Guideline

Helicobacter Pylori Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Helicobacter pylori and gastric or duodenal ulcer.

Prescrire international, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of Proton Pump Inhibitors in Gastric Ulcer Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended proton pump inhibitor (PPI) regimen for treating stomach ulcers caused by Helicobacter pylori (H. pylori)?
What is the recommended treatment for peptic ulcers?
What is an acceptable first-line treatment for peptic ulcer disease associated with a positive Helicobacter pylori (H. pylori) test?
Should a patient with stomach pain and nausea following meals, suspected of having a peptic ulcer, be initiated on Proton Pump Inhibitor (PPI) therapy, such as omeprazole (generic name), or should no intervention be done?
What is the recommended antibiotic regimen for a perforated duodenal ulcer?
What is the recommended albendazole dosing, duration, steroid use, monitoring, and alternatives for treating neurocysticercosis in an adult (≥12 years) without severe hepatic impairment?
Should serum aldolase be used to diagnose or monitor autoimmune hepatitis (AIH), and in which clinical situations is its measurement appropriate?
What other long‑term maintenance therapies are available for an adult with chronic obstructive pulmonary disease besides the budesonide/formoterol inhaler?
What is the rationale for establishing a separate haematology/oncology psychiatry subspecialty rather than managing these patients within general psychiatry?
Can a patient with ulcerative colitis taking Asacol (mesalamine) safely use Mobic (meloxicam) for pain, and what monitoring is needed?
What is the significance and recommended evaluation for low free T3 and low/normal free T4 with a normal TSH?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.